Maurer Martha A, Shiyanbola Olayinka O, Mott Mattigan L, Means Julia
Sonderegger Research Center for Improved Medication Outcomes, School of Pharmacy, University of Wisconsin-Madison School of Pharmacy, Madison, WI 53705, USA.
Division of Social and Administrative Sciences, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.
Pharmacy (Basel). 2022 Mar 10;10(2):37. doi: 10.3390/pharmacy10020037.
African Americans are more likely than non-Hispanic whites to be diagnosed with and die from diabetes. A contributing factor to these health disparities is African Americans' poor diabetes medication adherence that is due in part to sociocultural barriers (e.g., medicine and illness misperceptions), which negatively affect diabetes management. In our prior work, we engaged with community stakeholders to develop and test a brief version of a culturally adapted intervention to address these barriers to medication adherence. The objective of this study was to elicit feedback to inform the refinement of the full 8-week intervention. We utilized a community-engaged study design to conduct a series of meetings with two cohorts of patient advisory boards of African Americans with type 2 diabetes who were adherent to their diabetes medicines (i.e., peer ambassadors). In total, 15 peer ambassadors were paired with 21 African American participants (i.e., peer buddies) to provide specific intervention support as peers and serve in an advisory role as a board member. Data were collected during nine board meetings with the patient stakeholders. A qualitative thematic analysis of the data was conducted to synthesize the findings. Feedback from the patient advisory board contributed to refining the intervention in the immediate-term, short-term, and long-term. The inclusion of African American community members living with type 2 diabetes on the advisory board contributed to further tailoring the intervention to the specific needs of African Americans with type 2 diabetes in the community.
非裔美国人比非西班牙裔白人更有可能被诊断出患有糖尿病并死于糖尿病。这些健康差异的一个促成因素是非裔美国人对糖尿病药物的依从性较差,部分原因是社会文化障碍(例如,对药物和疾病的误解),这对糖尿病管理产生了负面影响。在我们之前的工作中,我们与社区利益相关者合作,开发并测试了一个简短的文化适应性干预措施,以解决这些药物依从性障碍。本研究的目的是征求反馈意见,为完善为期8周的完整干预措施提供参考。我们采用社区参与式研究设计,与两组患有2型糖尿病且坚持服用糖尿病药物的非裔美国人患者咨询委员会(即同伴大使)举行了一系列会议。总共有15名同伴大使与21名非裔美国人参与者(即同伴伙伴)配对,以同伴身份提供具体的干预支持,并作为委员会成员发挥咨询作用。在与患者利益相关者举行的9次委员会会议期间收集了数据。对数据进行了定性主题分析,以综合研究结果。患者咨询委员会的反馈有助于在近期、短期和长期完善干预措施。咨询委员会中纳入患有2型糖尿病的非裔美国社区成员有助于进一步根据社区中患有2型糖尿病的非裔美国人的具体需求调整干预措施。